A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see mesalamine) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
Indication
For the treatment of Crohn's disease and rheumatoid arthritis as a second-line agent.
Pharmacology
Sulfasalazine is an anti-inflammatory indicated for the treatment of ulcerative colitis and rheumatoid arthritis.
Affected Organisms
Humans and other mammals
Half Life
5-10 hours
Elimination
The majority of 5-ASA stays within the colonic lumen and is excreted as 5-ASA and acetyl-5-ASA with the feces.
An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
参考文献
PubChem文献
数据源提供
• McDonnell, J.P., et al.: Anal. Profiles Drug Subs., 5, 515 (1972)
• Schroder, H., et al.: Clin. Pharmacol. Ther.,13, 539 (1972)
• Klotz, U., et al.: Clin. Pharmacokinet.,10, 285 (1972)